|
CA1241003A
|
|
DOPAMINE-.beta.-HYDROXYLASE INHIBITORS
|
|
CA1266482A1
|
|
6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
|
|
CA1205380A
|
|
Rabies vaccine
|
|
CA1243035A
|
|
Leukotriene antagonists
|
|
CA1238854A
|
|
ANTITUMOR PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING TUMORS EMPLOYING ¬.alpha.,W- BIS(DISUBSTITUTEDPHOSPHINO)HYDROCARBON| DIGOLD (I) DIGOLD (III), DISILVER (I) AND DICOPPER (I) DERIVATIVES
|
|
CA1198368A
|
|
Rabies vaccine
|
|
CA1238314A
|
|
Process for preparing basic heptapeptide vasopressin antagonists
|
|
CA1232917A
|
|
Leukotriene antagonists
|
|
CA1203185A
|
|
Cloned streptomycete gene
|
|
CA1183472A
|
|
Veterinary vaccines
|
|
CA1247086A
|
|
Renally active tetrapeptides
|
|
CA1128530A
|
|
MONOCYCLIC .beta.-LACTAMS WITH ANTIBACTERIAL ACTIVITY
|
|
CA1148860A
|
|
Gelatin capsule dosage unit containing triamterene
|
|
CA1090797A
|
|
Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1h- 3-benzazepine compounds
|
|
CA1072568A
|
|
5-cycloalkylthio- and oxy-2-carbalkoxyamino-benzimidazole
|
|
CA1069440A
|
|
Pharmaceutical compositions
|
|
CA1072078A
|
|
Cephalosporin compounds
|
|
CA1080622A
|
|
Hypolipidemic compositions and method of producing hypolipidemic activity
|
|
CA1064509A
|
|
Substituted 2h-pyran-2,6(3h)-dione derivatives
|
|
CA1003438A
|
|
.alpha.AMINOALKYL-4-HYDROXY-3-UREIDOBENZYL ALCOHOLS
|
